FDA turns 100
This article was originally published in The Tan Sheet
A formal ceremony commemorating FDA's 100-year anniversary is tentatively planned for June 30, the agency announces Jan 4. Other centennial events include a building dedication at the Federal Research Center located at FDA's White Oak campus tentatively scheduled for the fall. Several forums on "FDA's past and future" are planned for February through May in locations including Texas, California and New York. The agency also has launched a 1website to mark the anniversary, which provides information on FDA history and a Centennial Quiz...
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.